{"ticker": {"uuid": "a995e659-0033-4abf-b32b-fac45bbf7c53", "symbol": "PRM", "name": "Proteome Sciences plc", "exchange": "LSE", "country": "GB", "sector": "Healthcare", "industry": "Diagnostics & Research"}, "articles": [{"title": "Proteome Sciences Secures New Chemoproteomics Contract Ahead of Planned 2026 Clinical Programme (PRM)", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxQU0RYZE16VENKeUxFUWc3aWNhMWZQekFuaDRJQ2NTZnNHVlJXSm1pcWRFXzliLUtOVFJWY1d4d0FPT0xCdGZJQ0hkcGxhUzc3UzQzWi0tVmJYZTU4SUdsbWFKNDZReDVRY0FleENRd3NJNFhWLTVWZDZqWlByNEprLWNkOGE5a3Y4cGtWcGI4VUl3d0pSU2JpNjhrUTBLcHZU?oc=5", "source_name": "Market source", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher Stock - long-term strategy in life sciences", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxQTHdqczJiTzgxU2VwYnowLXhoanpKY0ZWX0dvMHF0OHc0NmJnREJPNmRCOTFNVUhjWkY2RTdaUklONUpxRC1qaG9rMG9Jbi1vTkhTM3NzbUljYUstUFdwejEtZWhMd2Y1UVZ1azRqTGpRbVM5SFZ4RENHeUdWZ3Y0NDdQWjd0czhPaHZ3Si1CSjQ2NlpOdWM0V19RUUw5dGV5a2ZSaklsbi1yc1pJ?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-06-20T07:00:00+00:00", "published_display": "20 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Proteome Sciences shares jump 19% after landing $1.5m of new contracts", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxPMkNfci1FcnpRLTFrYlZ0RUhhdXZJRjRvZWMxR0lEWTVKaXBFMjZXc1o5Rm5ZeTZBT3hTY2x1bExJdlpMWnExNjVYRV80bE5lbGp3a0Nwb0ZSOUZpb2dBem9QTTkza0x6VnVoVnVSd1ZLRVRwNExkTHFrYml6QXJJcEZBa0pyY1plbTQ5X3B3Qm9ZQkFWMi1CTS04RzFvVWswTms1UVJWTU9oWW5FRmxTV1gyODZCclJSSXp2UjZ5UnlCWF8xenA3eUhJS0x5MzZkamlfODQ4T04?oc=5", "source_name": "Proactive Investors", "published_at": "2026-01-06T08:00:00+00:00", "published_display": "06 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PRM Stock Price and Chart \u2014 LSE:PRM", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTFBGQ3R1cnhKT1M1RGZvLTdjOTBnekVOMkdPVFUtUGVHcGlJeV9TbURtVzdCYmszOVNhaEtlRXFvSFctNE9BZTE1RV9lZ2NxM1M5LWRjMmMzUQ?oc=5", "source_name": "TradingView", "published_at": "2017-07-21T03:20:50+00:00", "published_display": "21 Jul 2017 03:20", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Proteome Sciences Secures New Chemoproteomics Contract Ahead of Planned 2026 Clinical Programme (PRM)", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxQU0RYZE16VENKeUxFUWc3aWNhMWZQekFuaDRJQ2NTZnNHVlJXSm1pcWRFXzliLUtOVFJWY1d4d0FPT0xCdGZJQ0hkcGxhUzc3UzQzWi0tVmJYZTU4SUdsbWFKNDZReDVRY0FleENRd3NJNFhWLTVWZDZqWlByNEprLWNkOGE5a3Y4cGtWcGI4VUl3d0pSU2JpNjhrUTBLcHZU?oc=5", "source_name": "Market source", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher Stock - long-term strategy in life sciences", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxQTHdqczJiTzgxU2VwYnowLXhoanpKY0ZWX0dvMHF0OHc0NmJnREJPNmRCOTFNVUhjWkY2RTdaUklONUpxRC1qaG9rMG9Jbi1vTkhTM3NzbUljYUstUFdwejEtZWhMd2Y1UVZ1azRqTGpRbVM5SFZ4RENHeUdWZ3Y0NDdQWjd0czhPaHZ3Si1CSjQ2NlpOdWM0V19RUUw5dGV5a2ZSaklsbi1yc1pJ?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-06-20T07:00:00+00:00", "published_display": "20 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Proteome Sciences shares jump 19% after landing $1.5m of new contracts", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxPMkNfci1FcnpRLTFrYlZ0RUhhdXZJRjRvZWMxR0lEWTVKaXBFMjZXc1o5Rm5ZeTZBT3hTY2x1bExJdlpMWnExNjVYRV80bE5lbGp3a0Nwb0ZSOUZpb2dBem9QTTkza0x6VnVoVnVSd1ZLRVRwNExkTHFrYml6QXJJcEZBa0pyY1plbTQ5X3B3Qm9ZQkFWMi1CTS04RzFvVWswTms1UVJWTU9oWW5FRmxTV1gyODZCclJSSXp2UjZ5UnlCWF8xenA3eUhJS0x5MzZkamlfODQ4T04?oc=5", "source_name": "Proactive Investors", "published_at": "2026-01-06T08:00:00+00:00", "published_display": "06 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PRM Stock Price and Chart \u2014 LSE:PRM", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTFBGQ3R1cnhKT1M1RGZvLTdjOTBnekVOMkdPVFUtUGVHcGlJeV9TbURtVzdCYmszOVNhaEtlRXFvSFctNE9BZTE1RV9lZ2NxM1M5LWRjMmMzUQ?oc=5", "source_name": "TradingView", "published_at": "2017-07-21T03:20:50+00:00", "published_display": "21 Jul 2017 03:20", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 85, "total_relevant": 4, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 4, "score": 50, "total": 4, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "deals", "primary_label": "Deals and strategy", "confidence": 62, "events": [{"event": "deals", "label": "Deals and strategy", "weight": 1.1, "count": 2}, {"event": "general", "label": "Market update", "weight": 1.1, "count": 2}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 0.02, "latest_week": "2026-07-10", "one_week_move": 4.6, "four_week_move": 9.7, "twelve_week_move": 21.4, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.417235, "market_dynamics_buy_signal": false, "relative_strength": -25.001418, "fair_value_gap": -51.2, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 37.483, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+4.6% over one week, +9.7% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 52, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Deals and strategy", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 1}, {"label": "Ad Hoc News", "count": 1}, {"label": "Proactive Investors", "count": 1}, {"label": "TradingView", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 4}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Deals and strategy", "count": 2}, {"label": "Market update", "count": 2}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Deals and strategy", "tone": "neutral", "text": "62/100 classification confidence."}, {"label": "Company focus", "value": "4", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+4.6% over one week, +9.7% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Proteome Sciences Secures New Chemoproteomics Contract Ahead of Planned 2026 Clinical Programme (PRM)"}], "updated_at": "2026-07-18T01:27:07.758501+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}